05/28/2026
We’re excited to announce the commercial launch of Syncell Discovery Services — a new global sample-to-discovery program providing researchers direct access to unbiased nanoscopic spatial proteomics powered by the Microscoop® Mint platform.
As demand grows for higher-resolution approaches in biomarker discovery, drug target identification, and disease biology research, Syncell Discovery Services enables biopharma, translational research groups, and academic labs to submit samples directly for in situ proteomic profiling with subcellular spatial precision.
From oncology and neuroscience to immunology and cell biology, researchers can now uncover proteins and spatial biology insights that are often inaccessible through conventional spatial proteomics workflows.
"This unbiased spatial optoproteomics approach allowed us, for the first time, to identify candidates in the protein adhesion complex at the whole proteome level, which we are now functionally validating as potential drug targets for cancer," said William Hwang, M.D, Ph.D., at Massachusetts General Hospital and Assistant Professor, Harvard Medical School.
Learn how Syncell Discovery Services can accelerate your discovery pipeline and unlock new therapeutic insights:
https://www.syncell.com/news-center/news/syncell-launches-high-precision-proteomics-discovery-service-powered-by-microscoop-mint-platform/